Global Pediatric Vaccine Market Set For 8.08% Growth, Reaching $59.31 Billion By 2028

The pediatric vaccine market report describes and explains the pediatric vaccine market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global pediatric vaccine market reached a value of nearly $41.16 billion in 2023, having grown at a compound annual growth rate (CAGR) of 6.71% since 2018. The market is expected to grow from $41.16 billion in 2023 to $59.31 billion in 2028 at a rate of 7.58%. The market is then expected to grow at a CAGR of 8.08% from 2028 and reach $87.46 billion in 2033.

What are the upcoming opportunities in the global pediatric vaccine market?
The key players in the market are adopting extensive strategies in the pediatric vaccine market such as:
Expanding operations through new vaccine approvals.
Strengthening market position via strategic partnerships.

Get The Complete Scope Of The Report
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

To take advantage of the opportunities, The Business Research Company recommends that pediatric vaccine companies focus on:
Developing new vaccines to address emerging health needs.
Focusing on conjugate vaccines to enhance immune response in children.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report
https://www.thebusinessresearchcompany.com/sample_request?id=2824&type=smp

Who are the major companies operating in the global pediatric vaccine market?
The global pediatric vaccine market is highly concentrated, with large players in the market. The top ten competitors in the market made up to 60.85% of the total market in 2023. The market concentration can be attributed to the presence of large players in different geographies. Merck & Co. Inc. was the largest competitor with a 30.82% share of the market, followed by:
SANOFI S.A.
Pfizer, Inc.
Seqirus (CSL Limited)
GlaxoSmithKline plc
Johnson & Johnson
Daiichi Sankyo Co. Ltd.
Novavax, Inc.
AstraZeneca Plc.
Novartis AG

We Offer Customized Report, Click Here
https://www.thebusinessresearchcompany.com/Customise?id=2824&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

This release was published on openPR.